131 related articles for article (PubMed ID: 20215751)
1. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
Doma S; Paladugu S; Parkman HP; Friedenberg FK
Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
3. Acid reflux immediately above the squamocolumnar junction and in the distal esophagus: simultaneous pH monitoring using the wireless capsule pH system.
Wenner J; Johnsson F; Johansson J; Oberg S
Am J Gastroenterol; 2006 Aug; 101(8):1734-41. PubMed ID: 16817841
[TBL] [Abstract][Full Text] [Related]
4. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
5. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
6. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
7. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory 24-hour double-probe pH monitoring: the importance of manometry.
Johnson PE; Koufman JA; Nowak LJ; Belafsky PC; Postma GN
Laryngoscope; 2001 Nov; 111(11 Pt 1):1970-5. PubMed ID: 11801980
[TBL] [Abstract][Full Text] [Related]
9. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
10. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment.
Pandolfino JE; Schreiner MA; Lee TJ; Zhang Q; Kahrilas PJ
Am J Gastroenterol; 2005 Aug; 100(8):1721-7. PubMed ID: 16086707
[TBL] [Abstract][Full Text] [Related]
11. Wireless ambulatory pH studies: manometric or endoscopic guidance?
Nusrat S; Roy PM; Bielefeldt K
Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
[TBL] [Abstract][Full Text] [Related]
12. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Loughney T; Maydonovitch CL; Wong RK
Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
[TBL] [Abstract][Full Text] [Related]
13. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
14. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory esophageal pH monitoring using a wireless system.
Pandolfino JE; Richter JE; Ours T; Guardino JM; Chapman J; Kahrilas PJ
Am J Gastroenterol; 2003 Apr; 98(4):740-9. PubMed ID: 12738450
[TBL] [Abstract][Full Text] [Related]
16. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.
Decktor DL; Krawet SH; Rodriguez SL; Robinson M; Castell DO
Am J Gastroenterol; 1996 Jun; 91(6):1162-6. PubMed ID: 8651164
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
18. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
19. Wireless pH recording immediately above the squamocolumnar junction improves the diagnostic performance of esophageal pH studies.
Wenner J; Hall M; Höglund P; Johansson J; Johnsson F; Oberg S
Am J Gastroenterol; 2008 Dec; 103(12):2977-85. PubMed ID: 18786112
[TBL] [Abstract][Full Text] [Related]
20. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?
Belafsky PC; Godin DA; Garcia JC; Rahim N
Laryngoscope; 2005 Jun; 115(6):1109-13. PubMed ID: 15933532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
